Here, “steep transition” is used descriptively to denote an appearance-level phenomenon: a small change in functional muscarinic braking is followed by a disproportionately large change in sinus rate over a short time window (Figure 1). Under anesthesia, vagal input to the sinoatrial node can vary rapidly, and acetylcholine at the effector site is delivered in brief, rapidly cleared pulses. Near the firing threshold of pacemaker activity, these pulse-to-pulse changes in effective muscarinic braking can translate into a non-proportional change in cycle length, making the pressure–HR trajectory look discontinuous (17–19). Mechanistically, muscarinic (M2) signaling slows pacemaker activity through Gi/o pathways and Gβγ-dependent activation of GIRK channels, providing a substrate in which modest changes in inhibitory current can produce a steep change in net diastolic depolarization rate (20, 21).

At the node level, coupled membrane-voltage and calcium-clock dynamics can further sharpen this effect near threshold, so that releasing inhibition can shift sinus rate abruptly rather than smoothly (22, 23).

Atropine can make this “threshold-crossing” behavior more visible because a bolus can rapidly reduce functional muscarinic braking once sufficient receptor blockade is achieved. Importantly, a large atropine response does not uniquely indicate “low vagal tone”; it may also occur when sympathetic drive or intrinsic chronotropic reserve is high, so the observed step reflects the momentary balance of inputs and effector gain rather than a single latent variable. Finally, atropine itself can show biphasic behavior at low doses and rare paradoxical bradyarrhythmias, which can further complicate bedside interpretation (24–27).

Accordingly, the observed atropine concentration–heart rate relationship at the bedside is not expected to be linear: small additional blockade near a functional threshold can produce a disproportionately large rate change, whereas similar concentration changes away from that threshold may have little visible effect.

Clinically, atropine sometimes produces little or no increase in sinus rate. Importantly, a “blunted response” does not uniquely indicate high vagal tone. Rather, the observed effect is context-dependent and can be shaped by multiple determinants—including, for example, how much functional muscarinic braking is actually present at the sinoatrial node, the sinus node's available chronotropic reserve under the prevailing anesthetic state, and the concurrent sympathetic background (drive or sympathoinhibition). With that in mind, several mechanistically distinct configurations can underlie a blunted atropine response; two broad, non-exclusive configurations are outlined below. (i)

Globally reduced autonomic responsiveness (system-level low gain).

Because these configurations can look similar at the bedside (“atropine didn't work”), interpretation should avoid a single-factor inference (e.g., “vagal tone must be high/low”). A more conservative reading is that a small observed sinus-rate change reflects limited expressed chronotropic reserve under the current anesthetic and reflex context, further shaped by the sympathetic background.

This scheme is offered as an interpretive heuristic—not a diagnostic taxonomy and not a statement about prevalence. Its main purpose is to extract interpretive hints when one of the two signals is missing or weakly expressed—i.e., when atropine produces little discernible sinus-rate change and/or when bedside evidence of reflex pressure–HR coupling is not apparent. When both signals are clearly present, the quadrant is included for completeness, but it typically adds less interpretive value because there is no “missing” element to explain.

“Atropine responsiveness” (a discernible rise in sinus rate after dosing) does not uniquely index baseline vagal tone. The observed response reflects the momentary balance between parasympathetic restraint, sympathetic background, and intrinsic sinus-node rate, and it can be shaped by dose/timing and competing reflex inputs (30, 31). Moreover, atropine effects can be non-monotonic across dose ranges in some settings, such that low-dose exposure may increase indices of vagal modulation while higher exposure produces the expected vagolytic chronotropic effect—underscoring that “responsiveness” should be interpreted cautiously and contextually rather than as a single-axis marker of vagal tone (24–26). Likewise, “reflex coupling” here refers only to bedside evidence of pressure–HR coupling (e.g., pressure rises accompanied by sinus slowing) rather than formal physiologic measurement of baroreflex function; the purpose is to organize what a response pattern may suggest about the autonomic context at that moment, while avoiding mechanistic over-interpretation.

(A) Minimal responsiveness × minimal coupling

At first glance, this quadrant might be expected to yield a more “linear-looking” pressor dose–pressure relationship because reflex-linked sinus slowing is not clearly expressed. However, because the defining feature is reduced readability of heart-rate modulation (low autonomic gain and/or substantial confounding), apparent linearity is not a reliable inference, and the pressure response may still be mechanistically ambiguous.

(B) Minimal responsiveness × coupling present

Because these possibilities are hard to disentangle without a change in context, repeated short-interval boluses in an otherwise unchanged setting may add limited interpretive value and can make causal attribution more difficult. In this quadrant, it is often more coherent to document the pattern and reassess after salient determinants of coupling and chronotropic expression have changed (e.g., anesthetic depth/exposure, ventilation/CO₂, stimulation/analgesia balance, co-vasoactives), rather than treating the observation as evidence of atropine “under-dosing” in isolation.

(C) Responsiveness present × coupling present—Reference pattern

Cardiac vagal decoupling is best regarded as a way of organizing hemodynamic reasoning rather than a standing order. Under many contemporary anesthetic combinations, reflex-mediated sinus slowing can become a practical obstacle when hypotension arises in a bradycardia-predominant state on a relatively vasoconstricted background. In that context, treating functional vagal influence at the sinoatrial node as a modifiable determinant helps explain why common reactive sequences (pressor escalation followed by later antimuscarinics) may yield modest, variable, or internally inconsistent pressure–HR trajectories.

Within this framework, a decoupling-oriented baseline can be considered before substantial pressor escalation in a subset of cases—particularly when (i) hypotension coexists with bradycardia or a low sinus rate that plausibly limits flow, and (ii) bedside observations remain consistent with reflex pressure–HR coupling (e.g., pressure rises accompanied by sinus slowing), under an anesthetic background in which volatile agents and opioids, with or without adjunctive α₂-agonists, plausibly shape autonomic gain. The aim is not to enforce tachycardia, but to establish a baseline in which subsequent adjustments of preload, vascular tone, and contractility are less likely to be repeatedly opposed by reflex sinus slowing, and in which antimuscarinics introduced after pressor initiation are less likely to coincide with abrupt trajectory discontinuities.

The four logical patterns combining atropine “responsiveness” and bedside evidence of reflex coupling (Table 1) are positioned as interpretive aids once atropine has been used during hemodynamic management: they summarize what an observed response (or non-response) may suggest about the autonomic context at that moment, without prescribing a specific drug sequence.

This framework remains subordinate to generic hemodynamic priorities. It is less informative or less attractive when it predictably magnifies arterial pressure or does not address the limiting factor—for example, during α₂-agonist concentration transitions with high vascular tone (risk of excessive hypertension), in advanced intrinsic atrioventricular block without pacing access (rate limited by conduction), in fixed-output lesions (rate changes do not improve forward flow), in profound hypovolemia (volume deficit predominates), or under intense β-blockade (limited sympathetic reserve).

Predicting an individual patient's response to hypotension or vasopressor challenge is inherently limited by state dependence: the same patient can show different pressure–HR coupling as anesthetic depth, ventilation/CO₂, surgical stimulation, temperature, and adjunct drug exposure change. Nevertheless, preoperative information can provide useful context once hypotension management is initiated. Baseline heart rate/rhythm and conduction status, chronic autonomically active medications (e.g., β-blockers), features suggestive of limited chronotropic reserve or autonomic dysfunction, and the planned anesthetic exposure pattern (e.g., volatile-sparing opioid-predominant techniques with or without α₂-agonists) may influence how readily reflex sinus slowing is expressed during pressor steps or how abruptly sinus rate changes after antimuscarinic dosing. In this framework, such information supports interpretation rather than a fixed intraoperative sequence; the evolving intraoperative pressure–HR trajectory remains the main basis for reassessing autonomic context as conditions change.

This framework is empirically testable and motivates two working hypotheses.

First, if reflex constraints meaningfully contribute to nonlinear pressure–heart rate trajectories under general anesthesia, then establishing a hemodynamic baseline with reduced functional vagal braking before substantial vasoactive escalation may be associated with weaker pressor-linked sinus slowing and a more proportional vasoactive dose–response. This could be examined by relating standardized pressor steps to paired changes in sinus rate and arterial pressure using prespecified pre/post windows.

Second, if hypertensive surges after late antimuscarinic dosing reflect abrupt removal of sinus-node vagal restraint on a high–vascular tone background, then earlier reduction of functional vagal braking may be associated with fewer or smaller post-antimuscarinic hypertensive overshoots compared with reactive sequencing (pressor first, antimuscarinic later). This could be quantified using peak MAP relative to a predefined clinical target range and/or time above that range within a prespecified post-dose interval.

These hypotheses are approachable using observational datasets and pragmatic trials based on routinely recorded hemodynamic variables and clinically relevant endpoints (e.g., vasoactive exposure, time to hemodynamic stability, and adverse events). Until such evidence is available, cardiac vagal decoupling is best presented as a physiologically grounded interpretive lens rather than as a prescriptive algorithm.

Arterial baroreflexes are indispensable in the awake state, yet under contemporary general anesthesia their heart-rate component can sometimes counteract intended hemodynamic management—particularly in bradycardia-predominant contexts where pressor-associated rises in arterial pressure are accompanied by sinus slowing and subsequent antimuscarinic dosing can produce abrupt changes in the paired pressure–heart rate response. In this article, we present cardiac vagal decoupling as a conceptual framework that treats functional vagal braking at the sinoatrial node as a clinically relevant constraint to consider explicitly when interpreting pressure–heart rate responses. The aim is not to promote tachycardia or to recommend a fixed drug sequence, but to improve the interpretability of vasoactive titration by reducing the likelihood that reflex-mediated sinus slowing dominates the observed response once intervention is underway. Whether this framework improves hemodynamic management beyond current reactive practice is an empirical question that will require prospective evaluation. Until such evidence is available, cardiac vagal decoupling is best presented as a physiologically grounded way to organize hemodynamic reasoning under anesthesia rather than as a prescriptive protocol.